4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-14-000727
$TCRTCIK 0001107421operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 3:36 PM ET
Size
7.1 KB
Accession
0001209191-14-000727
Insider Transaction Report
Form 4
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
- Tax Payment
Common Stock
2013-12-31$4.34/sh−7,193$31,218→ 45,594 total - Award
Employee Stock Option (Right to Buy)
2013-12-31+150,000→ 150,000 totalExercise: $4.34Exp: 2023-12-31→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]50,000 shares shall vest on each of 12/31/2014; 12/31/2015 and 12/31/2016.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 3:36 PM ET
- Size
- 7.1 KB